Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico. (2005). Farmeconomia. Health Economics and Therapeutic Pathways, 6(4), 289-300. https://doi.org/10.7175/fe.v6i4.849